| 660018 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Narrowband ultraviolet B therapy for refractory immune-related lichenoid dermatitis on PD-1 therapy: a case report |
2021-03-01 |
10.1136/jitc-2020-001831 |
Esfahani Khashayar, Henderson Berg Meagan-Helen, Zargham Hanieh, Billick Robin, Pehr Kevin, Redpath Margaret, Roshdy Osama, Miller Wilson H |
| 660017 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Severity of COVID-19 in patients with lung cancer: evidence and challenges |
2021-03-01 |
10.1136/jitc-2020-002266 |
Passaro Antonio, Bestvina Christine, Velez Velez Maria, Garassino Marina Chiara, Garon Edward, Peters Solange |
| 660016 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma |
2021-03-01 |
10.1136/jitc-2020-001703 |
Morales-Molina Alvaro, Gambera Stefano, Leo Angela, García-Castro Javier |
| 660015 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer |
2021-03-01 |
10.1136/jitc-2020-002084 |
Egelston Colt, Guo Weihua, Yost Susan, Lee Jin Sun, Rose David, Avalos Christian, Ye Jian, Frankel Paul, Schmolze Daniel, Waisman James, Lee Peter, Yuan Yuan |
| 660014 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Copy number loss in granzyme genes confers resistance to immune checkpoint inhibitor in nasopharyngeal carcinoma |
2021-03-01 |
10.1136/jitc-2020-002014 |
Ma Yuxiang, Chen Xi, Wang Ao, Zhao Hongyun, Lin Qingguang, Bao Hua, Zhang Yang, Hong Shaodong, Tang Wanxiangfu, Huang Yan, Yang Yunpeng, Wu Xue, Shao Yang, Fang Wenfeng, Zhang Li |
| 660013 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Extending the conversation over the immune-related hepatotoxicity: author response to Dr. Gauci et al |
2021-03-01 |
10.1136/jitc-2021-002391 |
Ziogas Dimitrios C, Gogas Helen |
| 660012 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G |
2021-03-01 |
10.1136/jitc-2020-001998 |
Anna François, Bole-Richard Elodie, LeMaoult Joel, Escande Marie, Lecomte Martin, Certoux Jean-Marie, Souque Philippe, Garnache Francine, Adotevi Olivier, Langlade-Demoyen Pierre, Loustau Maria, Caumartin Julien |
| 660011 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model |
2021-03-01 |
10.1136/jitc-2020-001963 |
Lee Yoke Seng, O'Brien Liam J, Walpole Carina M, Pearson Frances E, Leal-Rojas Ingrid M, Masterman Kelly-Anne, Atkinson Victoria, Barbour Andrew, Radford Kristen J |
| 660010 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination |
2021-03-01 |
10.1136/jitc-2020-001388 |
Wu Xiaofang, Nelson Marie, Basu Mousumi, Srinivasan Priya, Lazarski Christopher, Zhang Peng, Zheng Pan, Sandler Anthony David |
| 660009 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Fast progression in non–small cell lung cancer: results from the randomized phase III OAK study evaluating second-line atezolizumab versus docetaxel |
2021-03-01 |
10.1136/jitc-2020-001882 |
Gandara David, Reck Martin, Moro-Sibilot Denis, Mazieres Julien, Gadgeel Shirish, Morris Stefanie, Cardona Andres, Mendus Diana, Ballinger Marcus, Rittmeyer Achim, Peters Solange |
